Zyprexa Lawsuit News
"Wall Street Journal gets access to legal briefs "
January 26, 2004
Previously sealed briefs were exposed after the Wall Street Journal filed a motion to the court to have access to them. Two smaller, generic drug companies that believe Eli Lilly & Co. used a flawed clinical study in order to get the patent for Zyprexa sales, as well as failing to inform the patent officer of essential facts filed the briefs. Filed by Ivax Corp. and Dr. Reddy's Laboratories, Ivax wrote in its brief that, "Lilly was desperate to find some unexpected property of olanzapine (Zyprexa) to overcome the inevitable." Since the 1996 introduction of Zyprexa to the market, more than 14 million Zyprexa prescriptions worldwide have been made.
If you have suffered serious Zyprexa side effects and would like more information contact us to confer with a Zyprexa lawyer.
Homepage • Lawsuit • Alternatives • Heart Attack • Injuries • Warning • Withdrawal • Risk • Diabetes • Side Effects • Reports • Information • Zyprexa and Women • Resources • Safety • News • Lawsuit Evaluation • Site Map
Whether
or not Zyprexa and similar atypical antipsychotic drugs are linked to diabetes
is a question that will be answered in the Zyprexa lawsuits that have been
filed. Patients have reported deadly instances of Zyprexa side effects. There
are 288 reported cases of Zyprexa diabetes cases, including 23 deaths.
Zyprexa maker Eli Lilly has enjoyed large success with Zyprexa, with the drug
currently the world’s top selling schizophrenia medication. The Zyprexa
side effects causing Zyprexa lawsuits may begin slowing the company’s
current financial success. For more information on